Study of biodistribution properties of a new myocardial imaging agent 99mTc(N)(PNP5)(DBODC)+
-
-
Abstract
99TcmNDBODC5 for intravenous injection was prepared. The labelling yield was 95.0%±0.52%. Sixteen New Zealand rabbits were involved and planar gamma imaging was performed at 10 timepoint after injection of 99TcmNDBODC5. The radioactivity channes of organs were calculated by regions of interest (ROI) analysis. The 16 rabbits were divided into 4 groups and were sacrificed at 30, 60, 120, and 180 min after injection respectively. The activity for all excised organs were measured by γwell counting for calculating radiouptake. Myocardial uptake for 99TcmNDBODC5 is high. Though myocardial uptake was lower than 99TcmMIBI, the liver clearance for 99TcmNDBODC5 was more rapid than that of 99TcmMIBI. As early as 30 min after injection, 99TcmNDBODC5 hearttoliver ratio is 0.98±0.52 versus 0.56±0.19 for 99TcmMIBI (P<0.01). At 60 min postinjection, 99TcmNDBODC5 hearttoliver ratio improved to the peak value (1.18±0.57), compared with 0.71±0.29 for 99TcmMIBI, P<0.01. After 60 min, the hearttoliver ratio of 99TcmNDBODC5 was keeping at a high level until 180 min. 99TcmNDBODC5 exhibited rapid lung clearance, similar to that of 99TcmMIBI. The biodistribution in the isolated organs demonstrated the same trend. The rapid 99TcmNDBODC5 liver clearance may allow the earlier imaging, and overcome the photon scatter from the liver with high activity which interfered the inferoapical wall in myocardial images. 99TcmNDBODC5 is a promising new myocardial perfusion imaging agent with superior biodistribution properties.
-
-